Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children

Journal of Clinical Gastroenterology

Volumn 49, Issue 4, 2015, Pages 345-349

  Malespin, Miguel ^a   Sleesman, Brett ^a   Lau, Alan ^a   Wong, Shirley S ^a   Cotler, Scott J ^b  

^a UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chinese American children; Nonalcoholic fatty liver disease; Obesity; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALANINE AMINOTRANSFERASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; 25-HYDROXYVITAMIN D; LIPID; VITAMIN D;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASIAN AMERICAN; BODY MASS; CHILD; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; IMMIGRANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL; REPEAT PROCEDURE; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; CHINA; COMPLICATION; ETHNOLOGY; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ALANINE TRANSAMINASE; ASIAN AMERICANS; BODY MASS INDEX; CHILD; CHINA; FEMALE; HUMANS; LIPIDS; MALE; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OVERWEIGHT; PEDIATRIC OBESITY; PREVALENCE; SEX FACTORS; VITAMIN D;

EID: 84928351417     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000121     Document Type: Article

References (24)

1. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98:960-967.
2. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118: 1388-1393.
3. Welsh JA, Karpen S, Vos MB. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. J Pediatr. 2012;162:496-500.
4. Kistler KD, Molleston J, Unalp A, et al. Symptoms and quality of life in obese children and adolescents with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2010;31: 396-406.
5. Akin L, Kurtoglu S, Yikilmaz A, et al. Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation. Acta Paediatr. 2013;102:e107-e113.
6. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, et al. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut. 2009;58: 1538-1544.
7. Fan JG, Zhu J, Li XJ, et al. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol. 2005;20:1825-1832.
8. Zhou YJ, Li YY, Nie YQ, et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol. 2007;13:6419-6424.
9. Chan DF, Li AM, Chu WC, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord. 2004;28: 1257-1263.
10. United States Census 2010. Available at: http://www.census. gov. Accessed March 29, 2013.
11. Tabibian JH, Lazo M, Durazo FA, et al. Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population? J Gastroenterol Hepatol. 2011;26:501-509.
12. Cotler SJ, Dhamija MK, Luc BJ, et al. The prevalence and clinical correlates of elevated ALT levels in an urban Chinatown community. J Viral Hepat. 2010;17:148-152.
13. Centers for Disease Control and Prevention. Available at: http://apps.nccd.cdc.gov/dnpabmi/. Accessed March 29, 2013.
14. Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007; 120(suppl 4):S164-S192.
15. Barlow SE, and the Expert Committee. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(suppl 5):S213-S256.
16. Schwimmer JB, Dunn W, Norman GJ, et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastro-enterology. 2010;138:1357-1364, 64 e1-2.
17. Meng L, Luo N, Mi J. Impacts of types and degree of obesity on non-alcoholic fatty liver disease and related dyslipidemia in Chinese school-age children? Biomed Environ Sci. 2011;24:22-30.
18. Lin YC, Chang PF, Hu FC, et al. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children. J Pediatr. 2011;158: 740-744.
19. Lenders CM, Feldman HA, Von Scheven E, et al. Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr. 2009;90:459-467.
20. Roth CL, Elfers CT, Figlewicz DP, et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology. 2012;55:1103-1111.
21. Manco M, Ciampalini P, Nobili V. Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. Hepatology. 2010;51:2229.
22. Targher G, Bertolini L, Scala L, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17:517-524.
23. Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79:820-825.
24. Katz K, Brar PC, Parekh N, et al. Suspected nonalcoholic fatty liver disease is not associated with vitamin D status in adolescents after adjustment for obesity. J Obes. 2010;2010:496829.